logo

BHC

Bausch Health·NYSE
--
--(--)
--
--(--)
4.46 / 10
Netural

BHC's fundamental score is 4.5/10. Key strengths include an interest coverage ratio of 1.27 and positive Profit-MV, indicating healthy interest payment capacity and profit relative to market value. However, year-over-year revenue growth is only ~5.7%, signaling limited top-line expansion. Additional factors such as Days Sales Outstanding at 83.27 days and negative PB-ROE (-0.95) further temper the outlook. Overall, the company displays defensive characteristics but lacks growth momentum.

Fundamental(4.46)SentimentTechnical

Analysis Checks(6/10)

Revenue-MV
Value2.21
Score2/3
Weight16.11%
1M Return7.73%
Total operating revenue (YoY growth rate %)
Value5.72
Score1/3
Weight-1.20%
1M Return-0.79%
Days sales outstanding
Value83.27
Score1/3
Weight-2.26%
1M Return-1.57%
Profit-MV
Value1.47
Score2/3
Weight16.41%
1M Return8.45%
Net income-Revenue
Value-0.45
Score2/3
Weight16.43%
1M Return8.45%
PB-ROE
Value-0.95
Score3/3
Weight22.25%
1M Return12.83%
Interest coverage ratio (EBIT / Interest expense) (%)
Value1.27
Score2/3
Weight-1.64%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value5.69
Score1/3
Weight-1.16%
1M Return-0.76%
Asset-MV
Value-0.50
Score0/3
Weight11.72%
1M Return5.75%
Cash-MV
Value1.78
Score3/3
Weight23.35%
1M Return9.67%
Is BHC undervalued or overvalued?
  • BHC scores 4.46/10 on fundamentals and holds a Fair valuation at present. Backed by its 1582.35% ROE, 3.20% net margin, 6.02 P/E ratio, 6.12 P/B ratio, and 304.17% earnings growth, these metrics solidify its Netural investment rating.